Contrasting effects of aspirin on prostate cancer cells: Suppression of proliferation and induction of drug resistance

Prostate

Volumn 42, Issue 3, 2000, Pages 172-180

  Rotem, Ronit ^a   Tzivony, Yifaat ^a   Flescher, Eliezer ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adriamycin; Chemotherapy; Cytotoxicity; LNCaP; P glycoprotein; PSC833

Indexed keywords

ACETYLSALICYLIC ACID; ANDROGEN; DOXORUBICIN; GLYCOPROTEIN P; VALSPODAR;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CELL CYCLE; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG MIXTURE; HUMAN; HUMAN CELL; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; ASPIRIN; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; P-GLYCOPROTEIN; PLATELET AGGREGATION INHIBITORS; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0034651777     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(20000215)42:3<172::AID-PROS2>3.0.CO;2-R     Document Type: Article

References (33)

1. Marwick C. Aspirin's role in prevention now official. JAMA 1997;277:701-702.
2. Henneckens CH. Aspirin in the treatment and prevention of cardiovascular disease. Annu Rev Public Health 1997;18:37-49.
3. Konety BR, Getzenberg RH. Novel therapies for advanced prostate cancer. Semin Urol Oncol 1997;15:33-42.
4. Ara G, Teicher BA. Cyclooxygenase and lipoxygenase inhibitors in cancer therapy. Prostaglandins Leukotrienes Essent Fatty Acids 1996;54:3-16.
5. Pollard M, Chang CF, Luckert PH. Investigations on prostatic adenocarcinomas in rats. Oncology 1977;34:129-132.
6. Drago JR, Murray C. Control of metastases in the NB rat prostatic adenocarcinoma model. J Androl 1984;5:265-268.
7. Chin K-V, Tanaka S, Darlington G, Pastan I, Gottesman MM. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J Biol Chem 1990;265:221-226.
8. Jurivich DA, Sistonen L, Kroes RA, Morimoto RI. Effect of sodium salicylate on the human heat shock response. Science 1992; 255:1243-1245.
9. Yagoda A, Petrylak D. Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer. Cancer 1993;71:1098-1109.
10. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP. LNCaP model of human prostatic carcinoma. Cancer Res 1983;43:1809-1818.
11. Abramson S, Korchak H, Ludewig R, Edelson H, Haines K, Levin RI, Herman R, Rider L, Kimmel S, Weissmann G. Modes of action of aspirin-like drugs. Proc Natl Acad Sci USA 1985;82: 7227-7231.
12. Jackson RC. The problem of the quiescent cancer cell. Adv Enzyme Regul 1989;29:27-46.
13. Fisher GA, Sikic BI. Clinical studies with modulators of multidrug resistance. Hematol Oncol Clin North Am 1995;9:363-382.
14. Combates NJ, Rzepka RW, Chan Y-NP, Cohen D. NF-1L6, a member of the C/EBP family of transcription factors, binds and trans-activates the human MDR1 gene promoter. J Biol Chem 1994;269:29715-29719.
15. Trautwein C, Caelles C, van der Geer P, Hunter T, Karin M, Chojkler M. Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature 1993;364:544-547.
16. Combates NJ, Kwon PO, Rzepka RW, Cohen D. Involvement of the transcription factor NF-IL6 in phorbol ester induction of P-glycoprotein in U937 cells. Cell Growth Differ 1997;8:213-219.
17. Flescher E, Ledbetter JA, Ogawa N, Vela-Roch N, Fossum D, Dang H, Talal N. Induction of transcription factors in human T lymphocytes by aspirin-like drugs. Cell Immunol 1995;160:232-239.
18. Archinal-Mattheis A, Rzepka RW, Watanabe T, Kokubu N, Itoh Y, Combates NJ, Bair KW, Cohen D. Analysis of the interactions of SDZ PSC 833 ([3′-keto Bmt1-Val2]-cyclosporine), a multidrug resistance modulator, with P-glycoprotein. Oncol Res 1995;7: 603-610.
19. Jiang X-R, Kelsey SM, Wu Y-L, Newland AC. Circumvention of P-glycoprotein-mediated drug resistance in human leukemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833. Br J Haematol 1995;90:375-383.
20. Rose DP, Connolly JM. Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate 1991;18:243-254.
21. Fulton AM. Interactions of natural effector cells and prostaglandins in the control of metastasis. J Natl Cancer Inst 1987;78:735-741.
22. Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, Shiff SI, Rigas B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol 1996;52:237-245.
23. Teicher BA, Holden SA, Ara G, Liu J-TC Robinson MF, Flodgren P, Dupuis N, Northey D. Cyclooxygenase inhibitors: in vitro and in vivo effects on antitumor alkylating agents in the EMT-6 murine mammary carcinoma. Int J Oncol 1993;2:145-153.
24. Theyer G, Schirmbock M, Thalhammer T, Sherwood ER, Baumgartner G, Hamilton G. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines. J Urol 1993;150:1544-1547.
25. Ghosh J, Myers CE. Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun 1997;235:418-423.
26. Herrmann JL, Menter DG, Beham A, von Eschenbach A, McDonnell TJ. Regulation of lipid signaling pathways for cell survival and apoptosis by bcl-2 in prostate carcinoma cells. Exp Cell Res 1997;234:442-451.
27. Ghosh J, Myers CE Jr. Arachidonic acid metabolism and cancer of the prostate. Nutrition 1998;14:48-49.
28. Chaudry AA, Wahle KWJ, McClinton S, Moffat LEF. Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: effects of fatty acids and cyclooxygenase inhibitors. Int J Cancer 1994;57:176-180.
29. Gao X, Porter AT, Honn KV. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications. Adv Exp Med Biol 1997;407:41-53.
30. Higgs GA, Vane JR. Inhibition of cyclo-oxygenase and lipoxygenase. Br Med Bull 1983;39:265-270.
31. Palayoor ST, Bump EA, Calderwood SK, Bartol S, Coleman CN. Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells. Clin Cancer Res 1998;4:763-771.
32. Flescher E, Fossum D, Gray PJ, Fernandes G, Harper MJK, Talal N. Aspirin-like drugs prime human T cells. Modulation of intracellular calcium concentrations. J Immunol 1991;146:2553-2559.
33. Amici C, Rossi A, Santoro MG. Aspirin enhances thermotolerance in human erythroleukemic cells: an effect associated with the modulation of the heat shock response. Cancer Res 1995;55: 4452-4457.